acute pancreatitis

advertisement
MEDICAL MANAGEMENT
OF THE
ACUTE ABDOMEN
FERNANDO URRUTIA M.D.
ST LUKE’S EPISCOPAL HOSPITAL, METHODIST HOSPITAL
HOUSTON, TEXAS
CLINICAL DEFINITION
OF
ACUTE ABDOMEN
CLINICAL SCENARIO CHARACTERIZED BY SEVERE PAIN, OFTEN OF RAPID
ONSET, THAT PREVENTS BODILY MOVEMENTS.
PAIN FOR LONGER OF 6 HOURS, USSUALLY REQUIRES SURGICAL
INTERVENTION.
ACUTE ABDOMINAL PAIN

COMMON COMPLAINT

1 IN 20 VISITS TO AN ER IS FOR ABDOMINAL PAIN

½ OF THE PATIENTS WILL HAVE NON-SPECIFIC FINDINGS

½ OF THE PATIENTS WILL HAVE A SERIOUS DISORDER

FEW PATIENTS WILL HAVE LIFE-THREATENING DISORDERS.
THEREFORE
•
EVALUATION TO BE EFFICIENT
•
ACCURATE EARLY DIAGNOSIS
•
AVOID DELAYS' IN THE EVALUATION
•
AVOID OVER INVESTIGATIONS IN PATIENTS WITH SELLLIMITED DISORDERS.
APPROACH TO ACUTE CARE
1)
2)
RAPID ASSESSMENT OF THE PATIENT OVERALL
PHYSIOLOGIC STATE
THE “
ABC “ RULE
AIRWAY
IS THE PATIENT ABLE TO MAINTAIN AN AIRWAY ?
IS ASPIRATION AT RISK ?
CAN THE PATIENT MANAGE ORAL SECRETIONS ?
BREATHING

TACHYPNEA

USE OF ACCESSORY MUSCLES
CIRCULATION
1)
IS THE PATIENT IN SHOCK ?
PALLOR
CYANOSIS
HYPOTENSION
TACHYCARDIA
2)
IV ACCESS
3)
EVIDENCE OF ACTIVE BLEEDING ?
HEMODYNAMIC INSTABILITY

SURGICAL CONSULT STAT

RESUSCITATION OF THE PATIENT

PROTECTION OF AIRWAYS ( INTUBATION )
DEATH BEGINS IN RADIOLOGY
ADAGE IN ACUTE CARE SURGERY
REMAINDER
RESUSCITATION
PROCEED WITH DIAGNOSTIC IMAGINE
C
D
Severity
B
A
Time
IMAGING STUDIES
COMPUTED TOMOGRAPHY
CHANGED THE EVALUATION OF
ACUTE ABDOMINAL PAIN
CT WITH RENAL CALCULUS PROTOCOL
CT ARTERIOGRAPHY
ABDOMINAL SERIES
ULTRASONOGRAPHY
MRI
HIDA SCAN
ABDOMINAL PAIN IN THE E.R.
CAUSE
PATIENTS (%)
NONSPECIFIC ABDOMINAL PAIN
35
APPENDICITIS
17
BOWEL OBSTRUCTION
15
UROLOGIC DISEASE
6
BILIARY DISEASE
5
DIVERTICULAR DISEASE
4
PANCREATITIS
2
VASCULAR
1
MEDICAL OR METABOLIC
1
EXTRA-ABDOMINAL CAUSES
OF ACUTE ABDOMINAL PAIN
CARDIAC
MYOCARDIAL ISCHEMIA, MYOCARDITIS, ENDOCARDITIS
THORACIC
P.E, PLEURITIC PAIN
HEMATOLOGIC
HEMOLYTIC ANEMIA, LEUKEMIA
METABOLIC
UREMIA, DIABETIC KETOACIDOSIS, PORPHYRIA
EXTRA-ABDOMINAL CAUSES
OF ACUTE ABDOMINAL PAIN
TOXINS
INSECT BITES, LEAD POISONING
INFECTIONS
HERPES ZOSTER, TYPHOID FEVER, OSTEOMYELITIS
NEUROLOGIC
RADICULOPATHY, ABDOMINAL EPILEPSY
MISCELLANEOUS
FAMILIAL MEDITERRANEAN FEVER, PSYCHIATRIC DISORDERS
CAUSES OF NONSURGICAL PERITONITIS

SPONTANEOUS BACTERIAL PERITONITIS

CHRONIC AMBULATORY PERITONEAL DIALYSIS

MYCOBACTERIUM TUBERCULOSIS

AIDS

CHLAMYDIA TRACHOMATIS

NEISSERIA GONORRHEA (FITZ-HUGH-CURTIS SYNDROME)

RARE CAUSES
POLIARTERITIS NODOSA
SLE
SCLERODERMA
FAMILIAL MEDITERREAN FEVER
PHARMACOLOGIC MANAGEMENT
DO NOT DELAY NARCOTICS
SIR ZACHARY COPE:
“MORPHINE DOES LITTLE OR NOTHING TO STOP SERIOUS INTRAABDOMINAL DISEASE, BUT IT PUTS AN EFFICIENT SCREEN IN
FRONT OF THE SYMPTOMS”
PHARMACOLOGICAL MANAGEMENT
EARLY ADMINISTRATION OF ANALGESIA:
6 STUDIES HAVE CONCLUDED: (ANALGESIA VS PLACEBO)
MORE COMFORT FOR THE PATIENT
NO DELAY IN DIAGNOSIS
ANTIBIOTIC TREATMENT
CLINICAL SCENARIOS
CLINICAL SCENARIO #1
A PREVIOUSLY HEALTHY 45-YEAR OLD MAN PRESENTS WITH SEVERE
LOWER ABDOMINAL PAIN, WHICH STARTED 36 HOURS EARLIER. HE
REPORTS NAUSEA, ANOREXIA, AND VOMITING ASSOCIATED WITH ORAL
INTAKE.
ON PHYSICAL EXAMINATION, HIS TEMPERATURE IS 39 C AND HIS HEART
RATE IS 110 BEATS PER MINUTE. HE HAS GENERALIZED ABDOMINAL
TENDERNESS MOSTLY IN THE LEFT SIDE WITH PERITONEAL SIGNS.
CLINICAL SCENARIO # 1
CBC
WBC 17,000 WITH LEFT SHIFT
LFT, AMYLASE, LIPASE ARE NORMAL
URINE
NEGATIVE
ABDOMINAL CT SCAN
ACUTE DIVERTICULITIS
RELEVANCE OF THIS CASE
I.
PRESENTATION OF ACUTE ABDOMINAL PAIN
II.
MANAGEMENT COULD BE MEDICAL OR SURGICAL
III.
EARLY RECOGNITION IMPORTANT TO AVOID SURGERY
CLINICAL STAGES OF DIVERTICULAR DISEASE
CLINICAL STAGE
ASYMTOMATIC DIVERTICULAR DISEASE
SYMTOMATIC UNCOMPLICATED
DIVERTICULAR DISEASE (STAGE 1,2a)
COMPLICATED DIVERTICULAR DISEASE
SYMPTOMS/SIGNS
PRESENCE OF COLONIC
DIVERTICULI,NO CLINICAL SYMPTOMS
L.L.Q. ABDOMINAL PAIN
CHANGE IN BOWEL HABITS
NO LEUKOCYTOSIS,FEVER,OR
PERITONEAL SIGNS
PERFORATION OF DIVERTICULUM
FEVER,ELEVATED WBC
OBSTRUCTION
PERITONITIS
FISTULA
ABSCESS FORMATION
BLEEDING
HINCHEY’S CLASIFFICATION
INITIAL ASSESSMENT
SEVERITY OF DIVERTICULITIS
HINCHEY’S CRITERIA
RISK OF DEATH

> 5% FOR STAGE 1 OR 2

13% FOR STAGE 3

43% FOR STAGE 4
ARCH SURG 2000; 135-558-62
MEDICAL MANAGEMENT
DEPENDS ON CLINICAL STATUS
MILD ATTACK WITH GOOD ORAL INTAKE
( 7 TO 10 DAYS OF ANTIBIOTICS)
HOSPITALIZATION
POOR ORAL INTAKE
SEVERE PAIN
ILEUS OR EVIDENCE OF OBSTRUCTION
HINCHEY STAGE 2-3-4
HOSPITALIZED PATIENT
FOLLOW-UP
NO IMPROVEMENT OF PAIN,FEVER,OR LEUCOCYTOSIS IN 3 DAYS.
PHYSICAL EXAM WITH NEW FINDINGS OR EVIDENCE OF WORSENING
REPEAT CT SCAN
PERCUTANEOUS OR SURGICAL INTERVENTION
NATURAL HISTORY
OF
DIVERTICULITIS
85% ARE EFFECTIVELY MANAGED MEDICALLY
< 10% WILL REQUIRE SURGICAL MANAGEMENT
AFTER THE FIRST EPISODE
33% REMAIN ASYMTOMATIC
33% EPISODIC DISCONFORT WITHOUT DIVERTICULITIS (SPASTIC
DIVERTICULAR DISEASE)
33% WILL HAVE A SECOND EPISODE.
NATURAL HISTORY
OF
DIVERTICULITIS
SECOND ATTACK
1.
MORBIDITY INCREASES FROM 25% TO 50%
2.
MORTALITY INCREAES FROM 1.3% TO 5%
FACTS OF DIVERTICULITIS
PERCUTANEOUS DRAINAGE
> THAN 4 CMS PERCUTANEOUS DRAINAGE MAY BE
BENEFITIAL.
MAY ALLOW ELECTIVE RATHER THAN EMERGENCY SURGERY.
GROSS FECULENT MATERIAL TEND TO RESPONDE POORLY.
ACUTE DIVERTICULITIS
ABSCESS
ACUTE DIVERTICULITIS
DRAINED ABSCESS
CLINICAL SCENARIO
#2
59 YEAR OLD FEMALE, PRESENTS TO THE E.R. WITH A SUDDEN
ONSET OF SEVERE ABDOMINAL PAIN, GENERALIZED
ASSOCIATED TO A FORCEFUL BOWEL EVACUATION,
WITHOUT FEVER, NAUSEA, OR EMESIS. ON PHYSICAL
EXAMINATION, HER TEMPERATURE IS 37.8 C AND HER HEART
RATE IS 150, REGULAR-IRREGULAR. SHE HAS SOME
ABDOMINAL TENDERNESS, DIFFUSE, WITHOUT PERITONEAL
SIGNS.
CLINICAL SCENARIO
#2
INITIAL ASSESSMENT:
CBC
AMYLASE
LIPASE
LIVER PROFILE
U/A
WBC COUNT OF 11,000
HG 13.0
250 (90-140)
150 (100-300)
NORMAL
NEGATIVE
EKG
ATRIAL FIBRILLATION WITH RAPID V.R.
ABDOMINAL SERIES
MILD ILEUS
PLAIN FILM OF THE ABDOMEN
ILEUS
CLINICAL SCENARIO
#2
RELEVANT DATA ON INITIAL ASSESSMENT:
- SUDDEN ONSET OF SEVERE PAIN
- MINIMAL ABDOMINAL FINDINGS ON EXAM
- NON-SPECIFIC FINDINGS ON ABDOMINAL SERIES
- NO FINDINGS ON BLOOD WORK
- IRREGULAR HEART RATE (ATRIAL FIBRILLATION)
INTESTINAL ISCHEMIA
MEDICAL EMERGENCY
SUPERIOR MESENTERIC ARTERY ANGIOGRAM
EMBOLUS OCCLUDING THE SMA
INTESTINAL ISCHEMIA
1)- ONSET
2)- DURATION OF SYMPTOMS
3)- CAUSE OF THE INJURY
4)- AREAS AND LENGTH OF BOWEL AFFECTED
5)- VESSEL INVOLVED
6)- DEGREE OF COLLATERAL BLOOD FLOW
TREATMENT AND PROGNOSIS
CELIAC AXIS
SUPERIOR MESENTERIC ARTERY
INFERIOR MESENTERIC ARTERY
COLLATERAL AND ANASTOMIC
CIRCULATION
ABUNDANT IN STOMACH, DUODENUM AND RECTUM.
LIMITED IN SPLENIC FLEXURE AND SIGMOID COLON.
ISCHEMIC COLITIS
PATHOPHYSIOLOGY
OF
INTESTINAL ISCHEMIA
REDUCTION OF MESENTERIC BLOOD FLOW (UP TO 75%
REDUCTION)
OCCLUSION OF A MAYOR VESSEL
1)- VASOCONSTRICTION
2)- PRESSURE ELEVATION
3)- REDUCTION OF FLOW
BOWEL ISCHEMIA
ISCHEMIA
ISCHEMIC INJURY IS DUE FROM HYPOXIA AND REPERFUSION
REACTIVE OXIGEN RADICALS:
SUPEROXIDE
HYDROGEN PEROXIDE
HYDROXYL RADICALS
TISSULAR DAMAGE
NUCLEIC ACIDS
MENBRANE LIPIDS
ENZYMES
CELL LYSIS AND NECROSIS
ISCHEMIA
REPERFUSION
OXIGEN RADICALS
XANTHINE OXIDASE (XO)
MESENTERIC ISCHEMIA
ACUTE
MORE PREVALENT
CHRONIC
ARTERIAL
MORE PREVALENT
SMA EMBOLOUS (SAME)
NON-OCLUSSIVE MESENTERIC ISCHEMIA (NOMI)
SMA THROMBOSIS (SMAT)
FOCAL SEGMENTAL ISCHEMIA (FSI)
VENOUS
ACUTE MESENTERIC VENOUS THROMBOSIS (MVT)
FOCAL SEGMENTAL ISCHEMIA (FSI)
INCIDENCE OF AMI

SMAE
40 TO 50%

NOMI
20 TO 30%

SMAT
10 TO 20%
AGING
WIDESPREAD USE OF ICU
SURVIVAL OF CV CONDITIONS
REF 4
CLINICAL FEATURES
AMI
- HIGH INDEX OF SUSPICION
CHF
ARRHYTMIAS
HYPOTENSION
RECENT M.I.
VASOACTIVE MEDICATIONS (COCAINE)
HEMATOLOGICAL DISORDERS (THROMBOPHILIA)
X-RAYS IN AMI
•
PLAIN FILMS OF THE ABDOMEN
NORMAL BEFORE INFARCTION
ILEUS
PNEUMATOSIS
PORTAL-MESENTERIC VASCULAR GAS
X-RAYS IN AMI
PREDICTORS OF MORTALITY
29% IN PAT WITH NORMAL ABDOMINAL SERIES
78% IN PAT WITH ABNORMAL FINDINGS
J VASC SURGERY 2007;46:467-74
CT SCAN IN AMI

MOST IMPORTANT STUDY

ASSESMENT OF OTHER CAUSES OF ABDOMINAL PAIN

IDENTIFY ARTERIAL AND VENOUS THROMBOSIS

ASSESMENT OF ISCHEMIC BOWEL
COLON DILATION
BOWEL WALL THICKENING
LACK OF ENHANCEMENT OF ARTERIAL VASCULATURE
INTRAMURAL GAS
VASCULAR GAS
COMPUTED TOMOGRAPHY (CT)
ACUTE MESENTERIC ISCHEMIA
GAS IN THE PORTAL VEIN
COMPUTED TOMOGRAPHY (CT)
ACUTE MESENTERIC ISCHEMIA
PNEUMATOSIS
INTESTINALIS
LATE SIGN OF ISCHEMIC INJURY
BOWEL NECROSIS
EXPLORATORY LAPAROTOMY
OTHER MODALITIES
CT ANGIOGRAPHY
MAGNETIC RESONANCE ANGIOGRAPHY AND
VENOGRAPHY
DOPPLER FLOWMETRY
LAPAROSCOPY
SELECTIVE MESENTERIC
ANGIOGRAPHY

MAINSTAY IN DIAGNOSIS OF OCCLUSIVE-NONOCCLUSIVE M.I.

INITIAL TREATMENT

PAPAVERIN INFUSION
SELECTIVE MESENTERIC
ANGIOGRAPHY
DIFFICULTIES:
- CRITICALLY ILL PATIENTS
IMPRACTICAL
DELAYS IN SURGERY
ADVANTAGES:
- EARLY DIAGNOSIS
- ROADMAP FOR REVASCULARIZATION
TREATMENT OF AMI
BASED ON 4 OBSERVATIONS:
1)- DELAYS IN THE DIAGNOSIS
- MORTALITY RATE IS 70% TO 90%
2)- ANGIOGRAPHY IS USEFULL IN OCLUSSIVE AND NONOCLUSSIVE
DISEASE
3)- VASOCONSTRICCION CAN PERSIST EVEN AFTER SUCCESFULL TX
4)- VASOCOSTRICTION CAN BE RELEEVED BY VASODILATOR INFUSION.
INITIAL MANAGEMENT
AMI
RESUSCITATION
BROAD-SPECTRUM ANTIBIOTICS
(LEVOFLOXACIN, METRONIDAZOLE, PIPERACILLIN-TAZOBACTAM)
PRE-OPERATIVE ANGIOGRAPHY
MESENTERIC VASOCONSTRICTION
RELIEF OF MESENTERIC VASOCONSTRICTION IS ESSENTIAL
INFUSION OF THE PHOSPHODIESTERESE INHIBITOR PAPAVERINE
(30-60 MG/HOUR)
ACUTE MESENTERIC ISCHEMIA
CT SCAN
RESUCITATE THE
PATIENT CORRECT
PRECIPITATING
FACTORS
NO SIGNS OF
PERITONITIS
OBSERVE
PERITONITIS
LAPAROTOMY
OR
LAPAROSCOPY
NORMAL
HISTORY OF DVT
OR
HYPERCOAGULA
BLE STATE
CT VENOUS
PROTOCOL
CT SCAN
ABNORMAL
ABDOMINAL
ANGIOGRAM
ACUTE MESENTERIC ISCHEMIA
ABDOMINAL ANGIOGRAM
NO PERSISTEN
SIGNS OF
PERITONITIS
HEPARIN /
THROMBOLYTIC
AGENTS
MESENTERIC
VENOUS
THROMBOSIS
PERSISTENT
SIGNS OF
PERITONITIS
LAPAROTOMY
OR
LAPAROSCOPY
SHORT
ISCHEMIC
SEGMENT
EXTENSIVE
ISCHEMIC
INVOLVEMENT
NO
PERSISTENT
SIGNS OF
PERITONITIS
ANGIOGRAPHIC
EVIDENCE OF
COLLATERALS
GOOD
FILLING OF
SMA
OBSERVE
MAJOR
ARTERIAL
OCCLUSION
(NONEMBOLIC)
PERSISTENT
SIGNS OF
PERITONITIS
NO
ANGIOGRAPHIC
EVIDENCE OF
COLLATERALS
ABSENT OR
POOR
FEELING OF
SMA
CONTINUOUS
PAPAVERINE
INFUSION, IF
POSSIBLE
LAPAROTOMY
OR
LAPAROSCOPY
, ARTERIAL
RECONSTRUCTI
ON, AND/OR
BOWEL
RESECTION
SECOND-LOOK
IF APPROPRIATE
MINOR
ARTERIAL
OCCULUSION
OR EMBOLUS
NO PERSISTENT
SIGNS OF
PERITONITIS
PERSISTENT
SIGNS OF
PERITONITIS
CONTINUOUS
PAPAVARINE
INFUSION
OBSERVE
CONTINUOUS
PAPAVARINE
INFUSION
LAPAROTOMY
OR
LAPAROSCOPY
AND LOCAL
RESECTION
THROMBOLYTIC
AGENT OR HEPARIN
REPEAT
ANGIOGRAM
OBSERVE
NO
PERSISTENT
SIGN OF
PERITONITIS
MAJOR
EMBOLUS
PERSISTENT
SIGN OF
PERITONITIS
SELECTED
CASES: CI TO
SURGERY
GOOD
PERFUSION OF
THE DISTAL
MESENTERIC
VASCULAR BED
AFTER BOLUS
OF A
VASODILATOR
CONTINUOUS
PAPAVERINE
INFUSION
PREOPERATIVELY
CONTINUOUS
PAPAVERINE
INFUSION
EMBOLECTOMY
AND/OR
RESECTION
REPEAT
ANGIOGRAM
CONTINUOUS
PAPAVERINE
INFUSION
POSTOPERATI
VELY
THROMBOLYTIC
AGENT
REPEAT
ANGIOGRAM
AND
CONSIDER A
SECONDLOOK
OPERATION
NO PERSISTENT
SIGNS OF
PERITONITIS
CONTINUOUS
PAPAVARINE
INFUSION
SPLANCHNIC
VASOCONSTRI
CTION (NO
OCCLUSION)
PERSISTENT
SIGNS OF
PERITONITIS
CONTINUOUS
PAPAVARINE
INFUSION
OBSERVE
LAPAROTOMY
OR
LAPAROSCOPY
+/- RESECTION
REPEAT
ANGIOGRAM
CONTINUOUS
PAPAVARINE
INFUSION
POSTOPERATIVELY
REPEAT
ANGIOGRAM
AND CONSIDER
A SECONDLOOK
OPERATION
Stents & Angioplasty
National Inpatient Sample
Database

Admissions from 2005-2009 with a diagnosis of Acute Mesenteric
Ischemia.

Factors for consideration:

Age

Gender

Comorbidities
Open Procedure
1499 patients
Endovascular
502 patients
Outcomes (weighted)
Open (n=1495),
No. (%)
Endovascular (n=502)
No. (%)
P
value
587 (39.3)
125 (24.9)
0.010
Bowel resection
500.5 (33.4)
72.5 (14.4)
<.001
TPN
365.4 (24.4)
68.6 (13.7)
.025
Length of stay*,
day
17.1 + 1.07
12.9 + 1.11
.006
Mortality
TPN, Total parenteral nutrition
*Mean + standard deviation
Beaulieu R.J; Arnaoutakis K.D; Abularrage C.J: Efron D. T; Schneider E; Black III J.H. (2014). Comparison of open and endovascular
treatment of acute mesenteric ischemia. Journal of Vascular Surgery, 59 (1) 159-164.
Conclusion

Endovascular intervention has increase significantly

Decrease mortality

Shorter length of stay

Lower rate of bowel resection

Decrease need for TPN use
ANGIOGRAM 54 HOURS
POST-EMBOLECTOMY-PAPAVERIN INFUSION IN SMA
CASE # 3
A 56-YEAR-OLD WOMAN PRESENTS WITH SEVERE EPIGASTRIC
ABDOMINAL PAIN AND VOMITING OF 14 HOURS DURATION,
SYMTOMS THAT HAD DEVELOPED SHORTLY AFTER DINNER THE
PREVIOUS NIGHT.SHE HAS NOT HISTORY OF ALCOHOL USE, TAKES NO
MEDICATIONS, AND HAS NOT FAMILY HISTORY OF PANCREATITIS. ON
PHYSICAL EXAMINATION, SHE HAS A HEART RATE OF 110 BETAS PER
MINUTE AND MODERATE EPIGASTRIC ABDOMINAL TENDERNESS WITH
PERITONEAL SIGNS. THE WHITE-CELL COUNT IS 16,500 PER CUBIC
MILLIMETER, AND THE HEMATOCRIT IS 49 %. THE SERUM AMYLASE
LEVEL IS 1450 IU PER LITER, AND THE SERUM LIPASE LEVEL IS 3200 IU
PER LITER, THE SERUM ALT IS 280 IU PER LITER, AND THE SERUM LDH
LEVEL IS 860 IU PER LITER. CALCIUM, ALBUMIN,TRIGLYCERIDES, AND
ELECTROLYTES VALUES ARE NORMAL.
ABDOMINAL CT SCAN:
PANCREATITIS
ACUTE PANCREATITIS
ETIOLOGY OF THE PANCREATITIS
DETERMINE THE SEVERITY OF THE DISEASE
MEDICAL
MANAGEMENT
SURGICAL
OUTCOME OF ACUTE PANCREATITIS

75-80% will present will mild pancreatitis.
Interstitial Pancreatitis
OUTCOME OF ACUTE PANCREATITIS

20 % of patients with acute pancreatitis will present with a
severe course

10 to 30 % of this group will died.

The rate of death has not decline.
Br J Sur 2004;91;1243-4
RELEVANT IN THIS CASE
LIVER ENZYMES

Elevated AST/ALT in non-alcoholic patients is the best predictor of
biliary pancreatitis.

AST/ALT > 3 times the upper limits of normal.

Positive predictive value of 95% of gallstone pancreatitis.
Am J Gastro 1194;89;1863-6
ENDOSCOPIC RETRAOGRADE CHOLANGIOPANCREATOGRAPHY
ERCP
ERCP

Persistent biliary obstruction worsens the outcome and
increases the severity of acute pancreatitis, and
predisposes the patient to bacterial cholangitis.
NIH state of the science statement on ERCP 2002
ERCP IN BILIARY PANCREATITIS

3 Randomized trial with a total of 511 patients.

Dx of biliary pancreatitis.

Conservative Management VS ERCP
ERCP IN BILIARY PANCREATITIS

Lower risk of pancreatitis-associated complications in
the ERCP groups.

No significant ERCP complications.
Cochrane Database Syst Rev 2004;4;CD003630
PREDICTING SEVERE ACUTE PANCREATITIS

Identify high risk Patients.
(
Close MONITORING )
Laboratory Values
Clinical Parameters
Findings on Imaging Studies.
Obesity. ( BMI > 30 )
Genetic factors(MCP-1)
SEVERITY SCORES
RANSON’S SCORE
 Ranson’s
Score
0-2
3-4
5-6
7-8

ICU > 7 days
1%
24%
53%
75%

Death
3%
16%
40%
100%
APACHE II SCORE

Physiologic Variables











Rectal temperature.
Mean blood pressure.
Heart rate.
Respiratory Rate.
Oxygenation.
Arterial PH
Serum Sodium.
Serum Potassium.
Serum Creatinine.
Hematocrit.
White Blood Count.
PREDICTING SEVERE ACUTE PANCREATIS

Atlanta Criteria

Systemic complications

Disseminated intravascular coagulation.

Metabolic disturbances.( Acidosis )

Local Complications

Pancreatic Necrosis.

Pancreatic Abscess.

Pancreatic Pseudo cyst.
FACT
PREVENT MORBIDITY- MORTALITY
PANCREATIC NECROSIS
CLINICAL SCENARIO # 4
36 YEAR OLD FEMALE, PRESENTS TO THE ER DEPARTAMENT COMPLAING
OF 48 HOUR HISTORY OF SEVERE ABDOMINAL PAIN, ASSOCIATED TO
ABDOMINAL DISTENSION AND FEVER.
WAS WELL UNTIL 3 WEEKS PRIOR TO HER ER VISIT, WHEN SHE DEVELOPED
SEVERE DIARRHEA WITH MUCUS AND BLOODY STOOLS, ON AN
AVERAGE RANGE OF 8 TO 10 STOOLS A DAY
ON EXAM, THE PATIENT IS LETHARGIC, TACHYCARDIC, WITH A BP OF
90/60 IN DISTRESS, DEHYDRATED, FEBRILE.
ABDOMEN IS DISTENDED, TENDER TO PALPATION WITH MILD REBOUND,
AND DECREASED BOWEL SOUNDS.
CLINICAL SCENARIO # 4
CBC
WBC 17,000
HG 9.0 GMS
STOOLS
NEGATIVE FOR C. DIFF
NEGATIVE FOR O/P
+++ OCCULT BLOOD
ELECTROLYTES
K+ 2.9 MEQ/L
Toxic Megacolon
TOXIC MEGACOLON
DEFINITION:
ACUTE COLONIC DILATATION WITH A TRANSVERSE COLON
DIAMETER OF GREATER THAN 6 CMS (RADIOLOGY),AND LACK OF
HAUSTRATION OF THE COLON IN A PATIENT WITH A SEVERE ATTACK
OF COLITIS.
DIFFERENTIAL DIAGNOSIS:
INFECTIOUS
PSEUDOMEMBRANOUS COLITIS
CAN BE THE INITIAL PRESENTATION IN U.C. (5%)
MEDICAL MANAGEMENT
OF
TOXIC MEGACOLON
1.
TREATING THE UNDERLYING INFLAMMATION
2.
RESTORING COLONIC MOTILITY
3.
PREVENTING COLONIC PERFORATION
4.
SYSTEMIC ANTIBIOTICS
Hospitalization;
oral glucocorticoids or IV
glucocorticoids
GOOD RESPONSE
Taper glucocorticoids
maintenance therapy with 5ASA; consider adding 6-MP
or AZA
SUCCESSFUL TAPER
Continue maintenance
therapy
POOR RESPONSE
IV glucocorticoids
UNSUCCESSFUL TAPER
More prolonged taper; add
6-MP or AZA maintain with 6MP or AZA 9
GOOD RESPONSE
Convert to oral
glucocorticoids followed by
tapering; add 5-ASA;
consider adding 6-MP or AZA
UNSUCCESSFUL TAPER
Longer glucocorticoid taper;
maintain with 6-MP or AZA
SUCCESSFUL TAPER
Maintain with 6-MP or AZA
POOR RESPONSE
IV cyclosporine or IV
infliximab
POOR RESPONSE
Surgery
GOOD RESPONSE
Oral cyclosporine and oral
glucocorticoids; or maintain
with infliximab
Taper glucocorticoids add 6MP or AZA
Maintain on 6-MP or AZA;
discontinue cyclosporine
within 6 mo.
FACTS IN TOXIC MEGACOLON
MORTALITY:
44% WITH EMERGENT COLECTOMY WITH PERFORATION
2% WITH COLECTOMY WITHOUT PERFORATION
50% RESOLVES WITH MEDICAL THERAPY
48 – 72 HOURS (CRITICAL IN ASSESMENT)
50% OF SUCCESSFUL TREATMENT WILL REQUIRE COLECTOMY
CONCLUSSION
THE PATIENT
IS
THE PRIORITY
BE A TEAM PLAYER
MEDICAL
RADIOLOGICAL
SURGICAL
THE MAIN GOAL
SHOULD BE TO AVOID
MORBIDITY AND
MORTALITY
ACUTE ABDOMINAL PAIN
CAN BE CATASTROFIC
EARLY DIAGNOSIS AND
INTERVENTION ARE
CRITICAL
MANAGEMENT
OF
SEVERE ACTIVE ULCERATIVE COLITIS
ACUTE PANCREATITIS
FERNANDO URRUTIA, M.D.
ASSISTANT PROFESSOR OF MEDICINE
UNIVERSITY OF TEXAS
HOUSTON, TX
09-01-2007
CASE VIGNETTE

56 year old women

Presents with severe abdominal pain and vomiting for 14 hours
duration

No Hx of alcohol or medication use.

No family Hx of pancreatitis.
CASE VIGNETTE
On Physical examination:
 HR 110 per minute, with moderate epigastric
abdominal tenderness without peritoneal signs.
 WBC is 16,500
 Hematocrit is 49 %
 Amylase is 1450 IU, Lipase 3200 IU
 AST is 860 IU
 Ca,Triglycerides,Albumin,electrolytes are normal.

RISK FACTORS
 Gallstones
 Excessive Alcohol

intake
However, clinically induce pancreatitis, almost never develops in
most patients.
Lankisch PG.
Pancreas 2002;25;411-2
CAUSES OF PANCREATITIS







Hypertriglyceridemia
Duct obstruction (Tumor or P.D. )
Medications:(azathioprine,thiazides,estrogens,furosemide,pen
tamidine,sulfas)
Trauma
20% idiopathic
Genetic predisposition
Environmental susceptibility
Whitcomb DC
Gut 2004;53;1710-7
Pathology of Acute Interstitial
Pancreatitis
PATHOLOGY OF NECROTIZING
PANCREATITIS
STRATEGIES AND EVIDENCE
1- Diagnosis
2- Determine the cause:
Prevent recurrence
3- Management
DIAGNOSIS

Characteristics of abdominal pain and nausea.

Elevation of pancreatic enzymes.

Elevation of liver enzymes.

Levels of trypsinogen activation peptide.

Levels of trypsinogen-2

CT scan,MRI,Ultrasound.(May help in determine
the cause,r/o other causes of intraabdominal
pathology or complications)
ABDOMINAL PAIN

Gallstone pancreatitis (Pain is sudden, epigastric, radiates to the
back, described as a knife-like pain)

Metabolic causes (Less abrupt pain, poorly localized)
PANCREATIC ENZYMES





Serum amylase > 3 times upper limits of normal
ACUTE PANCREATITIS.
Lipase levels are in parallel with amylase.
Elevation means ongoing pancreatic inflammation.
Amylase normalizes faster than lipase.
Trypsinogen-2 levels
Kemppainen E
Gut 1997,41;690-5
DIAGNOSIS OF ACUTE PANCREATITIS
PHATOGENESIS
Inappropriate activation of trypsinogen to
trypsin.
 Lack of prompt elimination of active trypsin
inside the pancreas.
 Activation of pancreatic enzymes causes
pancreatic injury.
 INFLAMMATORY RESPONSE.

 Tissue
damage in the pancreas
 Progression beyond the pancreas
 Systemic inflammatory response syndrome
 Multiorgan failure or even DEATH.
IMAGING STUDIES

CT SCAN.

MRI.

Abdominal ultrasound.

MRCP.

Endoscopic ultrasonography EUS

ERCP.
IMAGING STUDIES
CONCEPTS

MRI better than CT for early duct disruption.

Ultrasound more sensitive that CT or MRI for detection of gallstones
or sludge.

EUS best test for biliary pancreatitis.

EUS may guide the use of emergent ERCP.
Hyperdense focus in distal common bile duct
Endoscopic view of an impacted common bile duct
stone
Endoscopic view of sphincterotomy and basket
extraction
Endoscopic view of sphincterotomy and basket
extraction
Endoscopic view of sphincterotomy and basket
extraction
Endoscopic view of sphincterotomy and basket
extraction
Balloon extraction of common bile duct stones
after sphincterotomy
Prospective endoscopic trials in gallstone
pancreatitis
HOSPITALIZATION

Severe Pain.

Vomiting, Dehydration

Signs of severe acute Pancreatitis.
TREATMENT

Primarily Supportive

Medications

Lexipafant(Inhibitor of platelet activating factor)

Somatostatin.

Protease inhibitors
Johnson CD
Gut 2001;48;62-9
SUPPORTIVE THERAPY

NPO.

IV Pain medication

Aggressive Hydration to prevent hemoconcentration.(250-500 ml of
crystalloid solution per hour)

Pulse oximetry.
PREDICTING SEVERE ACUTE PANCREATITIS
Laboratory

Inflammatory Markers:

Interleukin-6 levels.

C-Reactive protein levels.

PMN elastase.

Urinary TAP. ( Trypsinogen A.F )
PREDICTING SEVERE ACUTE PANCREATITIS
Clinical Parameters

Clinical Findings
 Thirst
 Poor
urine output
 Progressive tachycardia
 Tachypnea
 Hypoxemia
 Agitation
 Confusion
 Lack of improvement of Pain in 48 hours
PREDICTING SEVERE ACUTE
PANCREATITIS

Ranson’s Score

At Presentation:

Age
> 55 yr

Blood glucose.
> 200 mg

White Cell Count.

LDH
> 350 IU

AST
> 250 IU
> 16,000/mm
PREDICTING SEVERE ACUTE
PANCREATITIS

Ranson’s score:

Within 48 hours

Hematocrit.
>10% decrease

Serum Calcium.
< 8 mg/dl

Base deficit.
>4 mEq/Lt

Blood Urea Nitrogen.> 5 mg/dl

Fluid secuestration. > 6 Liters

Arteria Oxygen
<60 mm Hg
PREDICTING SEVERE ACUTE
PANCREATITIS

Ranson’s Score:

Indicated by a positive Score > 3 with one point for each positive factor.
APACHE II SCORE

12 Physiological Variables.

Patient Age.

Previous history of severe organ system insufficiency or
inmunocompromised state.
Acute Pancreatitis
Role of CT scan

Diagnosis in doubt

Prognosis

Severe or worsening course
Contrast-Enhanced CT

Rapid bolus

Dynamic sequential scanning

Does not appear to make pancreatitis worse (Arch.Surg 2000)
CT WITH PANCREATIC PROTOCOL
Hyperdense focus in distal common bile duct
INTERSTITIAL PANCREATITIS
PANCREATIC NECROSIS
PANCREATIC GAS
PSEUDOCYST
FLUID COLLECTION
Pancreatic Fluid
Collections
•
ACUTE FLUID COLLECTION
•
PSEUDOCYST
•
ABSCESS
•
PANCREATIC NECROSIS
•
INFECTED NECROSIS
PANCREATIC-FLUID COLLECTIONS

57 % of hospitalized Patients, will have fluid collection.

39% will have 2 areas involved.

33% will have 3 or more.

Resolves spontaneously 50%.
FLUID COLLECTIONS
ANALYSIS

Pancreatic Enzymes

Pancreatic Duct Disruption.

Pseudocyst

Ascites

Pleural effusions
FLUID COLLECTIONS

Initially are ill-Defined.

Tend to evolved over time.

Management is conservative.

However…
ANY CHANGE ?
FLUID COLLECTIONS
WARNINGS

Continues to enlarge

Causes Pain

Became Infected as suggested by fever, leucocytosis. or gas in fluid collection.

Compress adjacent organs:
MEDICAL-ENDOSCOPIC-SURGICAL THERAPY MAY BE
NEEDED.
PANCREATIC NECROSIS

Important Complication.

Means nonviable pancreatic parenchyma.

Can develop during first few days.

Associated with late complications and Death.

Necrotic Tissue very susceptible to infection.
NECROSIS
Infected necrosis can occur within first week of illness
© 2006 Current Medicine Group Ltd
PANCREATIC NECROSIS

Suspect if

Fever

Leukocytosis

Failure to Improve

Unexpected Deterioration
PANCREATIC NECROSIS

Diagnosis

Loss of tissue perfusion on contrast-enhanced CT scan.

Gas Bubbles within necrotic tissue.

Fine-needle aspiration of necrotic area by either CT or US guided.
Gram’s stain and culture.
NECROSIS SCORE

CT Severity Index

Necrosis Score

No Pancreatic necrosis

Necrosis of one third of Pancreas

Necrosis of one Half of Pancreas

Necrosis of >one Half of Pancreas
INFECTED PANCREATIC
NECROSIS
1.
CULTURE POSITIVITY OF TISSUE.
2.
36-71% OF PANCREATIC NECROSIS.
3.
2ND-3NR WEEK FOLLOWING ONSET.
4.
TYPICALLY POLYMICROBIAL.
5.
CT GUIDED ASPIRATION.
Guide lines for FNA in
ANP
SYSTEMIC TOXICITY
ABSENT
?
FNA
NO
DECREASING
NO
PERSISTING
OVERWHEALMING
YES
NO
INCREASING
YES
FNA in ANP
CT
US
96%
SENSITIVITY
SPECIFICITY
99%
88%
90%
TENNER S.W.J SUR 97
USE OF ANTIBIOTICS

No antibiotics for mild cases

Prophylactic antibiotics ?
ROLE OF ANTIBIOTICS

Prophylactic antibiotics ( Imipenen )

Reduced infectious complications (Line sepsis,Pulmonary,UTI,and
infected pancreatic necrosis)
Pederzoli P
Surg Gyne-Obstet 1993;176;480-3
ROLE OF ANTIBIOTICS

Trial by Nathems AB ( Pro Am Thorac Soc
2004;1;289-90 )
 Failed
to demonstrate difference in outcome among
patients TX with cipro and metronidazole VS placebo
 Prophylactic
 Antifungal
antibiotics ?
TX ?
Antibiotics for Acute Necrotizing
Pancreatitis:
Cochrane Database of Systematic
Review:
4 prospective randomized trials
ANTIBIOTICS IN ASP

Cochrane Database of Systematic Review: ( Antibiotics for 10-14
days )

Decreased the risk of superinfection.

Imipenen-cilastin- Excelent pancreatic tissue penetration.
NUTRITIONAL SUPPORT

Very important in severe Pancreatitis.

Best way to do it ?

Parenteral ?

Enteral ?
NUTRITIONAL SUPPORT

Al-Omran (Cochrane Database Syst Rev 2003;1;CD002837 ) 70 pat in
2 small trials.

Enteral VS Parenteral nutrition in severe acute pancreatitis.

No Advantage.

No difference in outcome.
NUTRITIONAL SUPPORT

Metha analysis: 6 randomized trails involving 263 pat ( BMJ
2004;328;1407 )

Better outcome with Enteral nutrition.

Decreased rate of Infections.

Decreased Surgical interventions.

Reduced Length of hospital stay.

Reduced Cost.
NUTRITIONAL SUPPORT

Ileus

Some patients can not obtain adequate caloric intake with enteral
feeds.

Failure to maintain enteral access.
THE TEN
COMMANDMETS FOR
SURGERY IN ACUTE
PANCREATITIS
Commandments: I-V

Not operate on clinically mild AP

Accept broad spectrum antibiotics to reduce
infection rates in CT confirmed PN

FNA to determine sterile from infected necrosis

Infected necrosis in the setting of clinical sepsis is
an indication for surgical drainage

Not operate on sterile necrosis
Commandments: VI-X
Not operate within 14 days of onset except for
selected cases
 Limit debridement to preserve organs
 Remove gallbladder in mild gallstone
pancreatitis
 Do not remove gallbladder in severe gallstone
pancreatitis until after recovery
 Accept sphincterotomy as an alternative to
cholecystectomy in unfit patients

DISCHARGE PLANNING

Determine the cause of pancreatitis.

Cholecystectomy should be done before D/C in mild cases.

ERCP/sphinterotomy in poor surgical candidates.

Control of lipids.

Cessation of alcohol intake.

Weight reduction.
DISCHARGE PLANNING
Hypercalcemia – Hyperparathyroidism or CA
 Discontinue Medications.
 Recurrent Pancreatitis:

 Ductal
strictures
 Pancreas Divisum
 Mass
 Autoimmune pancreatitis
 Genetic Susceptibility
 Idiopathic Pancreatitis ( Dragnov P. Gastro
2005;128;756-63 )
DISCHARGE PLANNING

Small low fat meals.

Enteral feeds in persistent pain or large pseudocyst.
SUMMARY

Enteral nutrition better if possible.

No consensus with prophylactic antibiotics.

Fast assessment of severity on admission.

Emergent ERCP has an important role in biliary pancreatitis.

Reserve antibiotics to patients with pancreatic necrosis of more the
30% of the pancreas.
THANK YOU
GALLSTONE PANCREATITIS

Increased among with women > age of 60

Highest with small stones Less than 5 mm.

Microlithiasis
Levy P
Pancreatology 2005;5;450-6
ALCOHOLIC PANCREATITIS

More common among men than women.

Appears to be dose dependent
NIH publication 1998.
PANCREATIC
NECROSIS
•
1 OR MORE AREAS OF NO ENHANCING GLAND
•
WITH RETROPERITONEAL FAT NECROSIS.
COMPLICATION OF PANCREATIC NECROSIS
DEATHS.
•
•
MAY APPEAR UP TO 48 HS AFTER ONSET.
ACCOUNT FOR 70-80% OF
PANCREATIC PSEUDOCYST

Asymptomatic – Conservative Tx

Symptomatic -- Drainage

Endoscopic Intervention

Radiological intervention

Surgically
PANCREATIC NECROSIS

Associated with:

Pancreatic Inflammation

Hypovolemia

Hypotension
LACK OF IMPROVEMENT

Failure to improve in 2-3 days

CT of the abdomen with pancreatic protocol.

Fluid collections

Pancreatic necrosis

Other complications
LACK OF IMPROVEMENT

Consider

Antibiotic therapy

Nutritional support
ACUTE PANCREATITIS

Necrotizing pancreatitis accounts for nearly all morbidity and
mortality
IMAGING STUDIES

Tumors.

Gallstones.

Local complications of pancreatitis.

Pancreas divisum.

Early duct disruption.

Dilated pancreatic duct.
OTHER SCORING METHODS

APACHE II SCORE:

The Acute Physiology and Chronic Health Evaluation
PROGNOSIS OF ACUTE
PANCREATITIS
ACUTE PANCREATITIS
RELEVANT FACTORS
COMMON CAUSE OF SEVERE ABDOMINAL PAIN
220,000 HOSPITAL ADMISSION PER YEAR
80 % HAVE A BENIGN COURSE MANAGED MEDICALLY
20% HAVE A SEVERE COURSE
10 TO 30% MORTALITY
ACUTE PANCREATITIS
INTESTINAL ISCHEMIA
ACUTE
ISCHEMIC INJURY TO THE GUT
CHRONIC
IMAGING
COMPUTED TOMOGRAPHY (CT)
ANGIOGRAPHY
OTHERS
COLONOSCOPY
MRA
mesenteric
ischemia
CAUSES OF ACUTE MESENTERIC
ISCHEMIA
CAUSE
FREQUENCY (%)
SMA EMBOLUS
50 (%)
NONOCCLUSIVE MESENTERIC ISCHEMIA
25 (%)
SMA THROMBOSIS
10 (%)
MESENTERIC VENOUS THROMBOSIS
10 (%)
FOCAL SEGMENTAL ISCHEMIA
5 (%)
SPRECTRUM OF BOWEL INJURY
1.
TRANSIENT ALTERATION OF BOWEL INJURY
2.
TRANSMURAL GRANGRENE
TYPES AND FREQUENCIES
OF
INTESTINAL ISCHEMIA
TYPE
FREQUENCY (%)
COLON ISCHEMIA
75%
ACUTE MESENTERIC ISCHEMIA
25%
FOCAL SEGMENTAL ISCHEMIA
< 5%
CHRONIC MESENTERIC ISCHEMIA
< 5%
CONCLUSION
Acute Pancreatitis
HOW SHOULD THE PATIENT BE FURTHER EVALUATED ?
ACUTE ABDOMINAL PAIN
POSTRATION:
ACUTE ABDOMINAL
PAIN
HEMODINAMICALLY
RLQ PAIN(GRADUAL
ONSET)
CT APPENDIX
PROTOCOL
RUQ PAIN
UNSTABLE
RESUSCITATION
URGENT SURGICAL
CONSULT
Acute Pancreatitis
HOW SHOULD THE PATIENT BE FURTHER EVALUATED ?
DIFERENTIAL DIAGNOSIS

ACUTE APPENDICITIS

INFLAMMATORY BOWEL DISEASE (CROHN’S DISEASE)

PELVIC INFLAMMATORY DISEASE

TUBAL PREGNANCY

CYSTITIS

ADVANCED COLONIC CANCER

INFECTION COLITIS
COMMON CAUSES
OF
ACUTE ABDOMINAL PAIN
o
Appendicitis
o
Cholecystitis
o
Pancreatitis
o
Diverticulitis
o
Perforated peptic ulcer
o
Small bowel obstruction
o
Mesenteric ischemia
o
Ruptured abdominal aortic aneurysm
o
Pelvic inflammatory disease---Ectopic pregnancy
CT FINDINGS IN DIVERTICULITIS
1.
INCREASED SOFT TISSUE DENSITYWITHIN PERICOLONIC FAT (98%)
2.
COLONIC DIVERTICULI (84%)
3.
BOWEL WALL THICKENING (70)
4.
SOFT TISSUE MASS, PHLEGMON,FLUID COLLECTION,ABSCESS (35%)
5.
SENSITIVITY
97%
6.
SPECIFICITY
100%
7.
POSITIVE PREDICTIVE VALUE
100%
8.
NEGATIVE PREDICTIVE VALUE 98%
9.
ALWAYS REMEMBER COLON CANCER AS INITIAL PRESENTATION
Anti-inflammatory
agents
PEER-VIEW
SLIDE 2.6
PAG 12
CLINICAL STAGES OF DIVERTICULAR DISEASE
STAGE 1
STAGE 2
DEVELOPMENT OF DIVERTICULI
a. Pericolitis
b. Pericolic phlegmon
c. Pericolic abscess
d. Pelvic or intra-abdominal
abscess
e. Bowel obstruction
f. Fistulization
g. Bacteremia and sepsis
h. Bleeding
Pathophysiology: Diverticulitis as a
Fiber Deficiency Disorder
Most evidence suggest that diverticular disease is a fiber deficiency disorder
Theoretical Progression From Diverticula Formation to Diverticulitis
Low-fiber diet
Diverticula
formation
Change in flora
(+ altered
immune
response)
Diverticulitis
Colitis
CLINICAL HISTORY
CHARACTER OF THE PAIN
ONSET
LOCATION
DESCRIPTION
RADIATION
INTENSITY
PAST MEDICAL HISTORY

PREVIOUS ABDOMINAL PAIN
RECURRENT PROBLEM

INTESTINAL OBSTRUCTION
NO PRIOR SURGERY

HISTORY OF SYSTEMIC ILLNESS
S.L.E
PHYSICAL EXAM

POSITION IN BED

TACHYPNEA

HYPOTENSION

IRREGULAR HEART RHYTHM

ABDOMINAL EXAM

RECTAL EXAM
METABOLIC ACIDOSIS
EKG
SPECIAL CIRCUMSTANCES
EXTREMES OF AGE
PREGNANCY
IMMUNOCOMPROMISED HOST
CLINICAL MANIFESTATIONS
ACUTE DIVERTICULITIS
VARIES WITH THE EXTENT OF THE DISEASE PROCESS.
THE CLASSIC CASE:
OBSTIPATION, DISTENSION, ABDOMINAL PAIN MOSTLY IN THE LEFT
LOWER QUADRANT.
LOW GRADE FEVER
LEUKOCYTOSIS
THE PATIENT WITH SEVERE ABDOMINAL PAIN
FREE PERFORATION
PERITONITIS
CLINICAL SCENARIO # 1
DIAGNOSIS
SEVERE ACUTE DIVERTICULITIS
CT SCAN IN AMI
EARLY SIGNS ARE NONSPECIFIC
LATE SIGNS REFLECT NECROTIC BOWEL
SENSITIVITY 92%
SPECIFICITY 100%
Acute Pancreatitis
HOW SHOULD THE PATIENT BE FURTHER EVALUATED ?
THE CLINICAL PROBLEM

220,000 hospital admissions per year.

Similar frequency among age groups.

The cause and likelihood of death varies according to age, race,
body-mass index, and other factors.
PREDICTING SEVERE ACUTE
PANCREATITIS

Is Defined by:

The presence of organ failure.

Local complications.

Both.
Knaus WA
Crit Care Med 1985;13:818-29
PREDICTING SEVERE ACUTE PANCREATITIS
A.
LABORATORY PARAMETERS
B.
CLINICAL PARAMETERS
C.
RANSON’S SCORE
D.
APACHE II SCORE
E.
ATLANTA CRITERIA
F.
CT SCAN FINDINGS.
INFLAMMATORY MARKERS
CT-GRADE

CT Severity Index

CT Grade

Normal pancreas (Grade A)

Focal or diffuse enlargement (Grade B)

Intrinsic changes; Fat stranding (Grade C)

Single;ill defined Collection of fluid (Grade D)

Multiple collection of fluid or gas in or adjacent to pancreas (Grade E)
SEVERITY SCORE
 CT
Severity. Index
0-3
4-6
7-10-

Complication
8%
35%
92%

Death
3%
6%
17%
FACTS OF DIVERTICULITIS
OPERATIVE INTERVENTION
< THAN 10% OF PATIENTS REQUIRE SURGERY
INDICATIONS FOR EMERGENCY SURGERY
GENERALIZED PERITONITIS
UNCONTROLLED SEPSIS
UNCONTAINED VISCERAL PERFORATION
LARGE, UNDRAINABLE ABSCESS
LACK OF IMPROVEMENT OR DETERIORATION WITHIN 3 DAYS
CLINICAL EVALUATION
1)
CAREFUL CLINICAL HISTORY
2)
ADEQUATE PHYSICAL EXAMINATION
3)
PERTINENT IMAGING STUDIES
LABORATORY DATA

COMPLETE BLOOD COUNT

ELECTROLYTES, BUN, CREATININE, GLUCOSE

URINALYSIS

PREGNANCY TEST

LIVER PROFILE

AMYLASE, LIPASE

STOOL EXAMINATION

EKG
GENERAL MANAGEMENT OF
DIVERTICULAR DISEASE
UNCOMPLICATED STAGE 1
HIGH-FIBER DIET +/- ANTISPASMODICS AND ANTIBIOTICS
MESALANINE (0FF-LABEL)
PROBIOTICS (UNCONTROLLED STUDIES)
COMPLICATED STAGE 2
NPO,LIQUID DIETS, ON-LIQUID DIETS, OR REGULAR DIETS
ANTIBIOTICS,
MESALANINE (OFF LABEL)
PROBIOTICS (UNCONTROLLED STUDIES)
BLOOD FLOW REGULATION
SYSTEMIC
HUMORAL
LOCAL
SYMPATHETIC NERVOUS SYSTEM BY ALFA ADRENERGIC RECEPTORS
VASOACTIVE SUBSTANCES
ANGOTENSIN II
VASOPRESSIN
PROSTAGLANDINS
CLINICAL FEATURES
HIGH INDEX OF SUSPICION
o
SUDDEN ONSET OF SEVERE ABDOMINAL PAIN
o
RAPID AND FORCEFULL BOWEL EVACUATION
o
MINIMAL OR NO ABDOMINAL SIGNS
o
LOCALIZED ABDOMINAL PAIN AND BLEEDING (ISCHEMIC
COLITIS)
o
ALTERED MENTAL STATUS (SEPSIS, METABOLIC ACIDOSIS)
LABORATORY FEATURES
o
LEUKOCYTOSIS
o
METABOLIC ACIDOSIS
o
ELEVATED PHOSPHATE
o
ELEVATED LACTATE
o
ELEVATED AMYLASE
> 15,000
MILD ELEVATION
INTESTINAL ENZYMES
o
DEAMINE OXIDASE
o
HEXOAMINIDASE
o
GLUTATHIONE
o
S TRANSFERASE
o
INTESTINAL FETAL-ACID BINDING PROTEIN
LACK OF SPECIFICITY/SENSITIVITY
(LATE-STATE DISEASE)
ENDOSCOPIC RETROGARDE CHOLANGIOPANCREATOGRAM

ROLE IN ACUTE BILIARY PANCREATITIS ?
Outcome

Mortality

Length of stay

Need for bowel resection

Use of TPN
Measurements of acute illness
severity in treatment groups
Lactic acidosis
Hypertension
ARDS
Open (n=1499)
No. (%)
Endovascular (n=502)
No. (%)
P
value
404 (30.0)
57 (11.4)
.0018
99 (6.6)
25 (4.9)
.54
472 (31.5)
35 (7.0)
<.001
ARDS, Acute respiratory distress syndrome
Beaulieu R.J; Arnaoutakis K.D; Abularrage C.J: Efron D. T; Schneider E; Black III J.H. (2014). Comparison of open and endovascular
treatment of acute mesenteric ischemia. Journal of Vascular Surgery, 59 (1) 159-164.
ERCP in Acute Pancreatitis
Conclusions

Consider only for gallstone pancreatitis

Cholangitis or significant biliary obstruction

Clinically severe but without ongoing biliary
obstruction, controversial

Consider EUS or MRCP

J Gastrointestinal Surgery 2001
PREDICTING SEVERE ACUTE PANCREATITIS

Atlanta Criteria:

Ranson Score > 3

APACHE II Score > 8

Organ Failure

Shock: SBP < 90 mm Hg

Pulmonary Insufficiency: pO2 < 60

Renal Failure: Creat. > 2 mg/dl

GI Bleed: 500 ml/24 hr
Download